Bayer Aktie 10367293 / DE000BAY0017
51.46
CHF
-0.15
CHF
-0.29%
18:00:00
BRX
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | Ausblick | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.96 |
| Temasek Holdings Pte Ltd. (Investment Management) | 3.52 |
| Norges Bank Investment Management | 3.15 |
| Harris Associates LP | 2.99 |
| Government Pension Fund - Global (The) | 2.77 |
| Vanguard Total International Stock Index Fund | 1.32 |
| Dodge & Cox International Stock Fund | 1.21 |
| Oakmark International Fund | 0.85 |
| Vanguard Developed Markets Index Fund | 0.78 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 116'998 | 103'824 | 99'538 | 99'637 | 101'369 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.34 | 0.42 | 0.42 | 0.44 | 0.50 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 32'197 | 31'760 | 35'002 | 31'994 | 37'247 |
| Summe Anlagevermögen | 87'199 | 86'308 | 72'154 | 73'823 | 80'235 |
| Summe Aktiva | 131'439 | 131'327 | 122'850 | 126'778 | 130'884 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 41'222 | 38'971 | 41'630 | 40'803 | 41'462 |
| Summe Fremdkapital | 85'291 | 83'810 | 92'151 | 93'610 | 91'958 |
| Summe Eigenkapital | 46'148 | 47'517 | 30'699 | 33'168 | 38'926 |
| Summe Passiva | 131'439 | 131'327 | 122'850 | 126'778 | 130'884 |
Adresse
| Kaiser-Wilhelm-Allee 1, 51368 Leverkusen | |
| Telefon | +49 (214) 30-1 |
| URL | http://www.bayer.com |
Management
|
Alan Schultz
Head-North America Project Procurement |
|
Alberto Weisser
Independent Member-Supervisory Board |
|
Andrea Sacher
Member-Supervisory Board |
|
André van Broich
Member-Supervisory Board |
|
Barbara Gansewendt
Member-Supervisory Board |
|
Bijoy Sagar
Chief Information Technology Officer |
|
Christian Rommel
Head-Research & Development |
|
Claudia Schade
Member-Supervisory Board |
|
Colleen A. Goggins
Independent Member-Supervisory Board |
|
Ertharin Cousin
Independent Member-Supervisory Board |
|
Francesco Grioli
Member-Supervisory Board |
|
Frank Löllgen
Member-Supervisory Board |
|
Frank Rittgen
Head-Mergers & Acquisitions |
|
Heike Hausfeld
Vice Chairman-Supervisory Board |
|
Heiko Willem-Jan Schipper
Member-Management Board |
|
Heinz Georg Webers
Member-Supervisory Board |
|
Horst Heinz Paul Baier
Independent Member-Supervisory Board |
|
Itziar Canamasas
Head-Oncology Europe, Middle East & Africa |
|
Kimberly Mathisen
Member-Supervisory Board |
|
Marianne de Backer
EVP & Head-Global Business Development & Licensing |
|
Michael Westmeier
Member-Supervisory Board |
|
Norbert W. Bischofberger
Independent Member-Supervisory Board |
|
Norbert Winkeljohann
Chairman-Supervisory Board |
|
Oliver Maier
Head-Investor Relations |
|
Otmar D. Wiestler
Independent Member-Supervisory Board |
|
Paul Achleitner
Member-Supervisory Board |
|
Rodrigo Santos
President-Crop Science Division |
|
Ruzha Draganova
Global HR Business Partner |
|
Sarena S. Lin
Chief Transformation & Talent Officer |
|
Simone Bagel-Trah
Member-Supervisory Board |
|
Stefan Oelrich
President-Pharmaceuticals Division |
|
Thomas Hoffmann
Head-Treasury |
|
Werner Baumann
Chairman-Management Board & CEO |
|
Wolfgang U. Nickl
Head-Finance |
|
Yasmin Fahimi
Member-Supervisory Board |